Cannabinoid Signalling Group
The Cannabinoid Signalling Group belongs to the Department of Biochemistry and Molecular Biology at the Schools of Chemistry and Biology of the Complutense University of Madrid.
Cannabinoid Signalling Group
The major focus of our group is the study of the mechanisms by which cannabinoids – the active components of Cannabis sativa L. – and their endogenous counterparts control the proliferation, differentiation and survival of different types of cells.
These are our research lines:
Recent publications
Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation (2024)
Tundidor, I. et al.
Cell Death Discovery
For more publications from Breast Cancer, click
here.
Δ9CB1 receptors in NG2 cells mediate cannabinoid-evoked functional myelin regeneration (2024)(2021)
Sánchez de la Torre, A. et al.
Prog Neurobiol
For more publications from Neurogénesis, click here.
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls (2024)
Costas-Insua, C. et al.
EMBO Mol Med
For more publications from Neuroprotection, click here.
Cellular stress responses as modulators of drug cytotoxicity in pharmacotherapy of glioblastoma (2024)
Kusaczuk, M. et al.
Biochim Biophys Acta Rev Cancer
For more publications from Brain Tumors, click here.
Acknowledgements
Our group acknowledges the support of funding institutions, both public and private.
